Inhalational anthrax

Known as: Inhalation anthrax, Pneumonia in anthrax, Pulmonary anthrax 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2017
012319732017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Bacillus anthracis was identified in a 61-year-old man hospitalized in Minnesota, USA. Cooperation between the hospital and the… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2014
2014
In the past decade, several Bacillus cereus strains have been isolated from otherwise healthy individuals who succumbed to… (More)
  • figure 1
  • table 1
Is this relevant?
2013
2013
Our laboratory previously described the binding characteristics of the murine IgG3 monoclonal antibody (MuAb) F26G3. This… (More)
  • figure 1
  • figure 2
Is this relevant?
2009
2009
Latex agglutination has been used to detect capsular polysaccharides from a variety of bacteria in body fluids. A latex… (More)
Is this relevant?
2007
2007
Bacillus anthracis is surrounded by a polypeptide capsule composed of poly-gamma-d-glutamic acid (gammaDPGA). In a previous study… (More)
Is this relevant?
2006
2006
Bacillus anthracis, the etiologic agent of anthrax, produces at least three primary virulence factors: lethal toxin, edema toxin… (More)
Is this relevant?
2003
2003
Inhalational anthrax (IA) is a rapidly progressive disease that frequently results in sepsis and death, and prompt recognition is… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1993
1993
Hemorrhagic lymphadenitis of the intrathoracic lymph nodes and mediastinitis are shown to be the primary septical focus, this… (More)
Is this relevant?
1976
1976
 
Is this relevant?
1973
1973
 
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
Is this relevant?